Mono Pharmacare Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Operating Revenue	1,430	1,223	330.87	369.83	282.66	116.87
Other Revenue	1.03	0.95	0.57	1.1	1.12	-
Revenue	1,431	1,224	331.44	370.93	283.78	116.87
Revenue Growth (YoY)	87.77%	269.41%	-10.65%	30.71%	142.81%	-
Cost of Revenue	1,297	1,107	292.42	347.3	265.87	99
Gross Profit	133.42	117.6	39.02	23.63	17.91	17.87
Selling, General & Admin	34.03	35.14	10.34	7.44	7.19	9.59
Other Operating Expenses	26.41	18.22	5.7	2.28	1.13	3.87
Operating Expenses	61.73	54.51	16.55	10.8	9.61	14.51
Operating Income	71.69	63.09	22.48	12.84	8.31	3.36
Interest Expense	-31.49	-30.83	-8.46	-6.55	-6.45	-1.75
Interest & Investment Income	-	-	0.03	0.09	-	0.02
Other Non Operating Income (Expenses)	0.15	-	-0.86	-0.87	-0.17	-1.15
Pretax Income	40.35	32.26	13.18	5.51	1.69	0.48
Income Tax Expense	11.49	7.67	3.73	2	0.74	0.28
Earnings From Continuing Operations	28.86	24.59	9.45	3.51	0.95	0.2
Minority Interest in Earnings	-0.16	-0.17	-0.02	-	-	-
Net Income	28.7	24.42	9.44	3.51	0.95	0.2
Net Income to Common	28.7	24.42	9.44	3.51	0.95	0.2
Net Income Growth	29.63%	158.84%	168.91%	268.98%	377.89%	-
Shares Outstanding (Basic)	18	15	6	5	5	5
Shares Outstanding (Diluted)	18	15	6	5	5	5
Shares Change (YoY)	80.03%	172.89%	15.18%	-	-	-
EPS (Basic)	1.62	1.58	1.67	0.71	0.19	0.04
EPS (Diluted)	1.62	1.58	1.67	0.71	0.19	0.04
EPS Growth	-27.99%	-5.15%	134.45%	274.94%	400.00%	-
Free Cash Flow	-	-	-401.73	2.26	-8.47	6.48
Free Cash Flow Per Share	-	-	-70.92	0.46	-1.72	1.32
Gross Margin	9.32%	9.60%	11.77%	6.37%	6.31%	15.29%
Operating Margin	5.01%	5.15%	6.78%	3.46%	2.93%	2.88%
Profit Margin	2.01%	1.99%	2.85%	0.95%	0.34%	0.17%
Free Cash Flow Margin	-	-	-121.21%	0.61%	-2.99%	5.54%
EBITDA	72.33	63.6	22.98	13.92	9.59	4.41
EBITDA Margin	5.06%	5.19%	6.93%	3.75%	3.38%	3.78%
D&A For EBITDA	0.64	0.51	0.51	1.08	1.28	1.05
EBIT	71.69	63.09	22.48	12.84	8.31	3.36
EBIT Margin	5.01%	5.15%	6.78%	3.46%	2.93%	2.88%
Effective Tax Rate	28.48%	23.78%	28.27%	36.30%	43.76%	58.63%
Revenue as Reported	1,431	1,224	331.48	371.03	283.78	116.89
Advertising Expenses	-	-	1.21	0.32	1.24	1.88

Source: S&P Capital IQ. Standard template. Financial Sources.